$RBKB

Loughlin Suzanne purchased $149K of RBKB

Loughlin Suzanne purchased 12,500 shares of Rhinebeck Bancorp, Inc. (RBKB) at an average of $11.93 ($11.92–$11.93, $0.15M total) across 2 trades on 2026-07-22.

Original reporting
SEC EDGAR · Loughlin Suzanne
Published Jul 23, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 12:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RBKB
Neutral
low confidence
Mentioned
$RBKB
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RBKBNeutralLow
01

Why it matters

The newest fact is the director’s open-market purchase of 12,500 shares at an average price of about $11.9296, with holdings after the transaction of 46,828 shares.

02

Market read

Traders may note the insider buying as a small sentiment input, but there is no accompanying fundamental update to reprice the stock materially.

03

What to watch

No context is provided on prior trading history, option exercises, or whether the purchase was part of a broader planned activity; also, the price range is narrow, suggesting execution around a set level rather than a new information-driven bet.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-23 after trades on 2026-07-22

Background

The article is an SEC Form 4 insider transaction disclosure for Rhinebeck Bancorp, Inc. (RBKB).

Company-level read

Ticker impact

$RBKBNeutralLow confidence
Context

Rhinebeck Bancorp director Loughlin Suzanne bought 12,500 shares in open-market trades at about $11.93 on 2026-07-22, per Form 4.

Expected impact

Likely limited near-term impact; any effect is small and short-lived unless followed by additional disclosures.

Evidence & confidence

The filing is an insider Form 4 purchase with no 10b5-1 plan and no accompanying guidance, contract, or operational update. The transaction size is meaningful but not typically market-moving for a small-cap bank without corroborating news.

Market effects

No clear sector read-through; this is company-specific insider activity.

None indicated beyond local bank sentiment.

None.

Counterpoint

Insider purchases can be routine liquidity or diversification rather than a strong forward-looking signal, especially without a clear thesis in the filing.

Key entities

  • Rhinebeck Bancorp, Inc.

    US-listed bank whose director filed an insider purchase on Form 4.

  • Loughlin Suzanne

    Director who purchased 12,500 shares in open-market trades on 2026-07-22.

Related articles

$RBKBMed

Rhinebeck Bancorp, Inc. Reports Results for the Quarter Ended June 30, 2026 and Completes Second-Step Conversion

Rhinebeck Bancorp (NASDAQ:RBKB) reported Q2 2026 net income of $2.6 million ($0.24/share), down from $2.7 million ($0.25/share) a year earlier. Six-month net income fell to $4.8 million. On July 21, 2026 it completed a second-step conversion, selling 8,880,210 shares at $10.00 for $88.8 million gross proceeds and issuing 15,638,237 shares post-transaction.

$RBKBMed

Rhinebeck Bancorp, Inc. (RBKB): Results of Operations and Financial Condition

Rhinebeck Bancorp, Inc. (RBKB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 rbkb-20260723xex99d1.htm EX-99.1 Rhinebeck Bancorp, Inc. Reports Results for the Quarter Ended June 30, 2026 and Completes Second-Step Conversion ​ News provided by Rhinebeck Bancorp, Inc. Poughkeepsie, New York, July 23, 2026 /ACCESSWIRE/ Rhinebeck Bancorp, Inc. (the “

$RBKBMed

Rhinebeck Bancorp, Inc. Announces Subscription Offering Results and Expected Closing Date

Rhinebeck Bancorp, Inc. (RBKB) reported results for its subscription offering tied to the mutual-to-stock conversion of Rhinebeck Bancorp MHC. The June 18, 2026 offering was oversubscribed in the first tier. Allocation follows its May 14, 2026 prospectus. The company expects closing on July 21, 2026, with trading continuing under RBKB and new shares starting July 22.

$RBKBMedAI 9/10

Rhinebeck Bancorp, Inc. Announces Commencement of Stock Offering

Rhinebeck Bancorp (NASDAQ: RBKB) began a stock offering tied to the proposed “second-step” conversion from Rhinebeck Bancorp, MHC to a stock holding company. It plans to sell up to 8,912,500 shares at $10.00 each, with at least 6,587,500 shares required to complete the conversion. Completion depends on regulatory, depositor, and stockholder approvals.

$RBKBMedAI 9/10

Rhinebeck Bancorp, Inc. Announces Commencement of Stock Offering

Rhinebeck Bancorp (NASDAQ:RBKB) began a stock offering tied to the proposed “second-step” conversion from mutual holding company to stock holding company. It plans to sell up to 8,912,500 common shares at $10.00 each, with at least 6,587,500 shares required to complete the conversion, subject to regulatory and shareholder approvals.

$RBKBMedAI 9/10

Rhinebeck Bancorp, Inc. Announces Commencement of Stock Offering

Rhinebeck Bancorp (NASDAQ:RBKB) began a stock offering tied to the proposed “second-step” conversion from mutual to stock form. It plans to sell up to 8,912,500 common shares at $10.00 each, with at least 6,587,500 shares required to complete the conversion. Final approvals from regulators, stockholders, and depositors are pending. Keefe Bruyette & Woods is the marketing agent.